|
Disease |
|
|
|
Detail |
| hsa-let-7b |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-92 |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-99a |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-125a |
|
Unspecified |
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-125b |
|
Unspecified |
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-184 |
|
Causal |
Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. |
2007 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-128 |
|
Causal |
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. |
2009 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
The MYCN oncogene is a direct target of miR-34a. |
2008 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. |
2008 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Causal |
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.
|
2008 |
|
|
|
|
|
|
| hsa-miR-23b |
|
Unspecified |
Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3'untranslated region: a role for microRNA23b. |
2009 |
|
|
|
|
|
|